SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-22-072971
Filing Date
2022-06-21
Accepted
2022-06-21 16:26:09
Documents
2
Group Members
EMERGING TECHNOLOGY PARTNERS, LLCETP BIOHEALTH III FUND, L.P.ETP GLOBAL FUND L.P.HUIYING MEMORIAL FOUNDATION

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2218711d1_sc13da.htm SC 13D/A 213201
2 EXHIBIT 99.1 tm2218711d1_ex99-1.htm EX-99.1 10613
  Complete submission text file 0001104659-22-072971.txt   225381
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Subject) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-46247 | Film No.: 221028452
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ENTREMED, INC. 9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
He Wei-Wu (Filed by) CIK: 0001542073 (see all company filings)

Type: SC 13D/A